Literature DB >> 12208521

PIAS3 (protein inhibitor of activated STAT-3) modulates the transcriptional activation mediated by the nuclear receptor coactivator TIF2.

Ana M Jiménez-Lara1, Mattias J S Heine, Hinrich Gronemeyer.   

Abstract

PIAS3, a member of the protein inhibitor of activated STAT family, was found to interact in vivo and in vitro with TIF2, a previously described coactivator for nuclear receptors. The interaction is mediated by two distinct non-contiguous regions of TIF2. We found that TIF2-PIAS3 interaction occurs through a unique domain of PIAS3, very rich in acidic residues and conserved throughout the PIAS family. PIAS3 modulates the ability of TIF2 to mediate ligand-enhanced transcription activation positively or negatively, for different steroid receptors. Taken together, our results indicate a potential role of PIAS3 as transcriptional modulator of TIF2-mediated signalling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12208521     DOI: 10.1016/s0014-5793(02)03154-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  A novel role for protein inhibitor of activated STAT (PIAS) proteins in modulating the activity of Zimp7, a novel PIAS-like protein, in androgen receptor-mediated transcription.

Authors:  Yue Peng; Jane Lee; Chunfang Zhu; Zijie Sun
Journal:  J Biol Chem       Date:  2010-02-16       Impact factor: 5.157

2.  Tumor-derived mutations in the gene associated with retinoid interferon-induced mortality (GRIM-19) disrupt its anti-signal transducer and activator of transcription 3 (STAT3) activity and promote oncogenesis.

Authors:  Shreeram C Nallar; Sudhakar Kalakonda; Daniel J Lindner; Robert R Lorenz; Eric Lamarre; Xiao Weihua; Dhananjaya V Kalvakolanu
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

3.  The association and nuclear translocation of the PIAS3-STAT3 complex is ligand and time dependent.

Authors:  Snehal Dabir; Amy Kluge; Afshin Dowlati
Journal:  Mol Cancer Res       Date:  2009-11-10       Impact factor: 5.852

Review 4.  Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family.

Authors:  Jianming Xu; Ray-Chang Wu; Bert W O'Malley
Journal:  Nat Rev Cancer       Date:  2009-09       Impact factor: 60.716

5.  Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3).

Authors:  Jianyin Long; Guannan Wang; Isao Matsuura; Dongming He; Fang Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-22       Impact factor: 11.205

6.  Protein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life.

Authors:  Kelly A Wong; Rachel Kim; Heather Christofk; Jing Gao; Gregory Lawson; Hong Wu
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

7.  Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer.

Authors:  Yun-Yong Park; Kyounghyun Kim; Sang-Bae Kim; Bryan T Hennessy; Soo Mi Kim; Eun Sung Park; Jae Yun Lim; Jane Li; Yiling Lu; Ana Maria Gonzalez-Angulo; Woojin Jeong; Gordon B Mills; Stephen Safe; Ju-Seog Lee
Journal:  EMBO Mol Med       Date:  2011-12-15       Impact factor: 12.137

8.  Pathogenesis of prostate cancer and hormone refractory prostate cancer.

Authors:  J S Girling; H C Whitaker; I G Mills; D E Neal
Journal:  Indian J Urol       Date:  2007-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.